It has been observed that in diabetic patients treated only with metformin, methylation of liver SLC22A1 decreases (Garcia-Calzon et al., 2017), suggesting that diabetes may decrease OCT1 expression by increasing SLC22A1 methylation. The gene discussed is SLC22A1; the disease is diabetes mellitus.